Home › Prostaatkanker › Californië › Irvine
Prostaatkanker klinische studies in Irvine, CA
14 studies voor Prostaatkanker zoeken deelnemers op locaties in en rond Irvine (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RekruterenFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RekruterenFase 2
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
RekruterenFase 3
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
RekruterenFase 3
- UCLA Hematology/Oncology - Irvine, Irvine
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RekruterenFase 3
- City of Hope Lennar Foundation Cancer Center ( Site 0059), Irvine
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
RekruterenFase 1
- Hoag Memorial Hospital Presbyterian, Irvine
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RekruterenFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
Rekruteren
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
Rekruteren
- City of Hope at Irvine Lennar, Irvine
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RekruterenFase 3
- Research Site, Irvine
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RekruterenFase 3
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
- Kaiser Permanente-Irvine, Irvine
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RekruterenFase 2
- City of Hope at Irvine Lennar, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Irvine
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
RekruterenFase 2
- Hoag Memorial Hospital Presbyterian, Irvine
Prostaatkanker studies in andere steden
- New York City, NY103 studies
- Houston, TX76 studies
- Los Angeles, CA61 studies
- Boston, MA59 studies
- St. Louis, MO46 studies
- Chicago, IL45 studies
- San Francisco, CA45 studies
- Philadelphia, PA44 studies
- Baltimore, MD43 studies
- Nashville, TN43 studies
- Seattle, WA42 studies
- Washington, DC38 studies
Andere studies in Irvine
- Niet-kleincellige longkanker25 studies
- Borstkanker23 studies
- Kanker (alle vormen)17 studies
- Metastatische kanker16 studies
- Longkanker15 studies
- Multipel myeloom14 studies
- Eierstokkanker12 studies
- Plaveiselcelcarcinoom van hoofd en hals11 studies
- Blasenkanker11 studies
- Ziekte van Alzheimer11 studies
- Colorectale kanker10 studies
- Aldermeesklierkanker10 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.